Evonik Invests in Laxxon Medical for Mass Production of 3D Printed Pharmaceuticals
The venture capital arm of German chemicals firm Evonik has invested in Nevada-based 3D printed pharmaceutical firm Laxxon Medical to bring the mass production of 3D printed tablets closer to reality.